tirzepatide and prediabetes in Patients with Obesity During a 3-year study, most patients reverted to normoglycemia. https://jwat.ch/4eFTJD8 Tirzepatide Cuts Risk of Diabetes

Kidney Disease Patients with acute or worsening kidney disease are advised against Semaglutide

Ozcan, U

The newly approved oral optionoften referred to as Oral Wegovyallows for higher dosing (up to 25 mg or 50 mg), which clinical trials have shown is necessary to trigger significant weight loss comparable to the injectable versions

Two points are worth being clear about

The concept of incretin effect was first proposed by Creutzfeldt in the 1970s (1, 2), based on the early observations that insulin secretion was two to three times higher after oral glucose intake than that after an isocaloric intravenous glucose administration (35)

Real-World Experiences: Weight Loss Injections Over 50 Patient stories from The Best of Health community show how these medications work in practice